HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongxin Zhang Selected Research

Neurologic Manifestations (Neurological Manifestations)

1/2020Neuroprotective Action of Teriflunomide in a Mouse Model of Transient Middle Cerebral Artery Occlusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yongxin Zhang Research Topics

Disease

18Ischemic Stroke
02/2024 - 10/2019
15Neoplasms (Cancer)
06/2024 - 07/2010
14Infections
06/2024 - 03/2002
10Stroke (Strokes)
02/2024 - 01/2020
5Inflammation (Inflammations)
01/2023 - 01/2021
4COVID-19
12/2022 - 01/2021
4Cerebral Infarction
10/2022 - 04/2020
4Human Influenza (Influenza)
01/2022 - 06/2007
3Neoplasm Metastasis (Metastasis)
05/2024 - 01/2022
3Bacterial Infections (Bacterial Infection)
04/2024 - 11/2022
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2024 - 01/2020
3Zika Virus Infection
01/2024 - 01/2020
3Inborn Genetic Diseases (Disease, Hereditary)
10/2023 - 01/2022
3Wounds and Injuries (Trauma)
07/2023 - 01/2022
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 11/2020
3Infarction (Infarctions)
04/2020 - 10/2019
2Stomach Neoplasms (Stomach Cancer)
05/2024 - 03/2024
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2024 - 04/2020
2Hypertension (High Blood Pressure)
01/2023 - 10/2022
2Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2022 - 09/2020
2Brain Injuries (Brain Injury)
01/2022 - 04/2020
2Tuberculosis (Tuberculoses)
01/2022 - 07/2012
2Neuroinflammatory Diseases
04/2020 - 01/2020
2Aneurysm (Aneurysms)
09/2017 - 07/2016
1Cognitive Dysfunction
04/2024
1Alzheimer Disease (Alzheimer's Disease)
04/2024
1Thrombosis (Thrombus)
02/2024
1Brain Infarction
02/2024
1Dry Eye Syndromes (Dry Eye Syndrome)
02/2024
1Insulin Resistance
01/2024
1Nerve Degeneration
01/2024
1Obesity
01/2024
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2024
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2023
1Hepatocellular Carcinoma (Hepatoma)
09/2023
1Blindness (Hysterical Blindness)
07/2023
1Corneal Injuries
07/2023
1Corneal Diseases (Corneal Disease)
07/2023
1Leukoaraiosis
02/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023

Drug/Important Bio-Agent (IBA)

8VaccinesIBA
06/2024 - 02/2011
7AntigensIBA
06/2024 - 01/2008
6Tissue Plasminogen Activator (Alteplase)FDA Link
02/2024 - 01/2020
5Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2010
4Glucose (Dextrose)FDA LinkGeneric
02/2024 - 01/2021
3Immune Checkpoint InhibitorsIBA
05/2024 - 01/2022
3Circular RNAIBA
03/2024 - 01/2022
3HydrogelsIBA
07/2023 - 01/2022
3Antiviral Agents (Antivirals)IBA
12/2021 - 01/2015
3CateninsIBA
01/2021 - 10/2019
2Messenger RNA (mRNA)IBA
06/2024 - 05/2024
2mRNA VaccinesIBA
06/2024 - 05/2024
2Amyloid (Amyloid Fibrils)IBA
04/2024 - 01/2024
2CytokinesIBA
02/2024 - 02/2002
2Oxygen (Dioxygen)IBA
02/2024 - 01/2022
2ElementsIBA
10/2023 - 01/2022
2NanovaccinesIBA
01/2023 - 01/2022
2Viral RNAIBA
12/2022 - 11/2019
2RNA (Ribonucleic Acid)IBA
01/2022 - 08/2014
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 07/2010
2Hyaluronic Acid (Hyaluronan)IBA
12/2020 - 09/2020
2Metal-Organic FrameworksIBA
12/2020 - 09/2020
2Immunoglobulin A (IgA)IBA
04/2016 - 03/2002
2DNA VaccinesIBA
07/2010 - 06/2007
2NucleoproteinsIBA
11/2007 - 06/2007
1Transforming Growth Factor-beta Type II ReceptorIBA
05/2024
1Papillomavirus Vaccines (HPV Vaccines)IBA
05/2024
1tau Proteins (tau Protein)IBA
04/2024
1VimentinIBA
03/2024
1Interleukin-12 (IL 12)IBA
02/2024
1TNF Receptor-Associated Factor 1IBA
02/2024
1Scopolamine (Hyoscine)FDA Link
02/2024
1Ophthalmic Solutions (Eye Drops)IBA
02/2024
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2024
1Bile Acids and Salts (Bile Acids)IBA
01/2024
1Retinaldehyde (Retinal)IBA
01/2024
1LeptinIBA
01/2024
116S Ribosomal RNAIBA
01/2024
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2024
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2024
1CholesterolIBA
01/2024
1Antihypertensive Agents (Antihypertensives)IBA
12/2023
1Protein Kinases (Protein Kinase)IBA
10/2023
1Serine (L-Serine)FDA Link
10/2023
1Threonine (L-Threonine)FDA Link
10/2023
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2023
1Checkpoint Kinase 1IBA
10/2023
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
09/2023
1Alkaline PhosphataseIBA
09/2023

Therapy/Procedure

18Therapeutics
05/2024 - 04/2016
15Thrombectomy
02/2024 - 01/2020
5Immunotherapy
02/2024 - 07/2010
4Stents
01/2021 - 07/2016
2Photothermal Therapy
04/2024 - 01/2023
2Lasers (Laser)
04/2024 - 02/2021
2Anesthesia
07/2023 - 12/2017
2Punctures
01/2021 - 09/2020
1Ligation
02/2024
1Physical Therapy Modalities (Physical Therapy Technique)
02/2024
1Corneal Transplantation (Keratoplasty)
07/2023